NEW YORK (Reuters) -After months of Wall Street gyrations to the twists and turns of U.S. trade policy, signs suggest stock investors are becoming more resilient to developments and cautiously defaulting to optimism that they have weathered the worst of the tariff-related shocks. U.S. equities have edged higher over the past two weeks as they digest a sharp rally that...

NEW YORK (Reuters) -After months of Wall Street gyrations to the twists and turns of U.S. trade policy, signs suggest stock investors are becoming more resilient to developments and cautiously defaulting to optimism that they have weathered the worst of the tariff-related shocks. U.S. equities have edged higher over the past two weeks as they digest a sharp rally that...

05:26 AM EDT, 06/05/2025 (MT Newswires) -- Liminatus Pharma ( LIMN ) said late Wednesday that it is now compliant with the Nasdaq listing rule requiring a timely filing of reports with the US Securities and Exchange Commission. The company was notified of the noncompliance due to a delay in the filing of its quarterly report on Form 10-Q for...

As the Nasdaq 100 index is nearly 2% away from its all-time high, analysis suggests that it’s “easier to digest” the index’s premium valuation given the growth optimism for 2025 and 2026. What Happened: According to Adam Turnquist, the chief technical strategist at LPL Financial, the Nasdaq 100’s forward 12-month price-to-earnings ratio at 26.6 was above its 10-year average P/E...